Here, we report that IRES-mediated translation of utrophin A via eEF1A2 is a critical mechanism of regulating utrophin A expression and reveal the potential of repurposed drugs for treating DMD via this pathway. The gene discussed is EEF1A2; the disease is Duchenne muscular dystrophy.